RegisterLogin

DDO-8958

CAT: 0804-HY-172210Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-172210Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
DDO-8958 is an orally active and selective BET BD1 inhibitor with a KD of 5.6 nM for BRD4 BD1. DDO-8958 exhibits low nanomolar inhibitory activity against all BET BD1 bromodomains except for BRDT BD1. DDO-8958 can inhibit the proliferation and migration, induce apoptosis and cell cycle arrest of tumor cells. DDO-8958 has anti-tumor activity[1].
CAS Number
[3017180-18-3]
UNSPSC
12352005
Target
Apoptosis; Epigenetic Reader Domain
Related Pathways
Apoptosis; Epigenetics
Field of Research
Cancer
Smiles
FC1=C(C=C(C=C1C2=C3NC=NC3=NC=C2)OCC4COC4)C5=C(N(N=C5C)C)C
Molecular Formula
C22H22FN5O2
Molecular Weight
407.44
References & Citations
[1]Chen X, et al. Multi-Water Bridges Enable Design of BET BD1-Selective Inhibitors for Pancreatic Cancer Therapy. J Med Chem. 2025 Mar 13;68 (5) :5719-5735.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-149863DDO-8926
HY-153331-01DDO-2213
HY-144801ADDO-02005
HY-139301-01DDO-5936
HY-144634-01DDO-7263
HY-132233DDO-2093
HY-147125DDO-6600
HY-169947-01DDO-6079
HY-170668DDO-02267
HY-155489-01DDO-2728

Alternative Products

CatalogName
T205605-01DDO-8958
MBS387550-01Laninamivir (CS-8958)
A12998-100Laninamivir (CS-8958) 100mg
A12998-5Laninamivir (CS-8958) 5mg
A12998-50Laninamivir (CS-8958) 50mg
A12998-10Laninamivir (CS-8958) 10mg
A12998-25Laninamivir (CS-8958) 25mg
CSB-CL006593HUDDO
588344DDO (DASOX, DDO-1, DDO-2, FLJ45203, aspartic oxidase)
245248DDO (D-Aspartate Oxidase, DASOX, DDO-1, DDO-2, FLJ45203)

Popular Products